Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase InhibitorYi‐Yun Yu, Michael R. Michaelides, Gui‐Dong Zhu et al.|Journal of Medicinal Chemistry|2024Cited by 8
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R. Frey, Thomas D. Penning, Navendu Jana et al.|Journal of Medicinal Chemistry|2024Cited by 6